Please use this identifier to cite or link to this item:
https://hdl.handle.net/20.500.12530/56065
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Hernández Herrero, D | - |
dc.contributor.author | MIANGOLARRA-PAGE, JUAN CARLOS | - |
dc.date.accessioned | 2022-10-10T10:39:57Z | - |
dc.date.available | 2022-10-10T10:39:57Z | - |
dc.date.issued | 2019-12-30 | - |
dc.identifier.citation | Hernández Herrero D, Miangolarra Page JC. Descriptive analysis of the annual cost of treating spasticity with different types of botulinum toxin A. Neurologia (Engl Ed). 2019 Dec 30:S0213-4853(19)30134-3. doi: 10.1016/j.nrl.2019.10.006. Epub ahead of print. PMID: 31899014. | es_ES |
dc.identifier.issn | 2173-5808 | - |
dc.identifier.uri | https://hdl.handle.net/20.500.12530/56065 | - |
dc.description.abstract | Botulinum toxin A is the first-line treatment for localised spasticity. However, the economic impact of this treatment is not fully known. This study aimed to describe the real costs of botulinum toxin A for the treatment of adult patients with spasticity at a spasticity clinic pertaining to a rehabilitation service, over a period of one year. | es_ES |
dc.language.iso | es | es_ES |
dc.publisher | Elsevier BV | es_ES |
dc.relation.isversionof | Publisher's version | es_ES |
dc.rights | info:eu-repo/semantics/openAccess | es_ES |
dc.rights | Atribución-NoComercial-SinDerivadas 3.0 España | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/3.0/es/ | * |
dc.subject | Análisis de costes | es_ES |
dc.subject | Botulinum toxin A | es_ES |
dc.subject | Cost analysis | es_ES |
dc.subject | Espasticidad | es_ES |
dc.subject | España | es_ES |
dc.subject | Spain | es_ES |
dc.subject | Spasticity | es_ES |
dc.subject | Toxina botulínica A | es_ES |
dc.subject.mesh | Costs and Cost Analysis | es_ES |
dc.subject.mesh | Botulinum Toxins, Type A | es_ES |
dc.subject.mesh | Muscle Spasticity | es_ES |
dc.title | Análisis descriptivo de coste de tratamiento de la espasticidad con diferentes tipos de toxina botulínica A, a lo largo de un año | es_ES |
dc.type | Artículo | es_ES |
dc.identifier.pubmedID | 31899014 | es_ES |
dc.format.volume | 37 | es_ES |
dc.format.page | 653-660 | es_ES |
dc.description.peerreviewed | Sí | es_ES |
dc.relation.publisherversion | https://doi.org/10.1016/j.nrl.2019.10.006 | es_ES |
dc.identifier.journal | Neurologia (Barcelona, Spain) | es_ES |
dc.identifier.journalabbreviation | Neurologia | es_ES |
dc.contributor.authoraffiliation | Servicio de Rehabilitación. Hospital universitario de Fuenlabrada | es_ES |
dc.format.number | 8 | es_ES |
dc.subject.decs | Espasticidad Muscular | es_ES |
dc.subject.decs | Toxinas Botulínicas Tipo A | es_ES |
dc.subject.decs | Costos y Análisis de Costo | es_ES |
Appears in Collections: | Hospitales > H. U. de Fuenlabrada > Artículos |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Rev Neurol.pdf | 275.87 kB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License